{
  "pmcid": "11825516",
  "sha256": "59a953208040a703d83e507446a81d986ac6e61b4af05d5c0467a6c4339f2190",
  "timestamp_utc": "2025-11-09T22:08:38.237679+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.576002664890076,
    "reading_ease": 27.11598267821452,
    "word_count": 237
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on the Impact of Perivascular Adipose Tissue Preservation in Coronary Artery Bypass Grafting"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "The unit of randomisation was the individual patient. Sample size calculation determined 200 participants were needed."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were patients undergoing CABG, with eligibility criteria including age 18-75 and diagnosis of CAD."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to either PVAT-preserved (intervention) or PVAT-removed (control) groups."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was graft patency at 12 months post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealment using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "200 participants were randomised: 100 to the intervention and 100 to the control group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was intention-to-treat."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The intervention group showed a higher graft patency rate (91% vs. 81%, p = 0.046)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were mild and occurred in 3% of the intervention group and 1% of the control group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678"
      },
      "Funding": {
        "score": 1,
        "evidence": "This trial was funded by the National Institutes of Health."
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}